The english version of the website of the School of Medicine is under development


Management of portal hypertension in children with portal vein thrombosis.

TitleManagement of portal hypertension in children with portal vein thrombosis.
Publication TypeJournal Article
Year of Publication2013
AuthorsGiouleme, O., & Theocharidou E.
JournalJ Pediatr Gastroenterol Nutr
Date Published2013 Oct
KeywordsAdrenergic beta-Antagonists, Child, Esophageal and Gastric Varices, Humans, Hypertension, Portal, Ligation, Portal Vein, Portasystemic Shunt, Surgical, Venous Thrombosis

Portal vein thrombosis (PVT) is a common cause of portal hypertension in children. Predisposing conditions for PVT are obscure in more than half of the cases. Variceal bleeding and splenomegaly are the most frequent initial manifestations. Radiologic imaging studies are the mainstay for diagnosis. Treatment includes pharmacologic, endoscopic, and surgical modalities. β-Adrenergic blockers are not routinely used in children because of unproven efficacy and significant adverse effects. Endoscopic methods, such as sclerotherapy and endoscopic variceal ligation (EVL), are highly effective in the treatment of acute variceal bleeding and eradication of varices. EVL is the treatment of choice because of minimal complications and the need for few endoscopic sessions. EVL facilitates portal decompression either by the formation of collateral vessels or by surgical portosystemic shunting, when vessels grow to the proper diameter for anastomosis. Surgical portosystemic shunts are reserved for refractory cases because of significant complications and technical difficulties. Transjugular portosystemic shunts have an emerging role in the management of portal hypertension caused by PVT. PVT may occur in the posttransplant setting, but optimal management is not defined yet.

Alternate JournalJ. Pediatr. Gastroenterol. Nutr.
PubMed ID23820400


Secretariat of the School of Medicine


Schoole of Medicince presence in social networks
Follow Us or Connect with us.